An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...

Darzalex, which treats multiple myeloma, has become the first Johnson & Johnson drug to ever top $3 billion in quarterly ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0626 ET – The Novo Nordisk Foundation is strongly interested in ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Conservatives are pushing Trump to distance himself from global health authorities, which experts believe could undermine future pandemic responses.

A New Mexican breakfast staple is going to cost an extra buck because eggs are costing a lotamore. Blake's Lotaburger announced Wednesday that it will tack on a $1 surcharge to all menu items that ...

J B Chemicals & Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives, Sale of services and Scrap for the year ending 31-Mar-2023.For ...